World's Best Scientists 2026 revealed!
Brian M. Zeglis

Brian M. Zeglis

D-Index & Metrics

Chemistry

D-Index
48
Citations
7739
World Ranking
15297
National Ranking
3875

Brian M. Zeglis publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Brian M. Zeglis sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 124 publications — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Brian M. Zeglis D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Brian M. Zeglis sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 48 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Brian M. Zeglis is a researcher affiliated with Hunter College in the United States, with a focus primarily in the field of medicine. Their work spans several subfields including radiology, nuclear medicine and imaging, oncology, molecular biology, pulmonary and respiratory medicine, and organic chemistry.

The scientist's research encompasses diverse topics, reflecting a broad interest in biomedical applications and chemical processes. Their main topics of work include:

  • Radiopharmaceutical Chemistry and Applications
  • Monoclonal and Polyclonal Antibodies Research
  • Peptidase Inhibition and Analysis
  • HER2/EGFR in Cancer Research
  • Click Chemistry and Applications
  • Chemical Synthesis and Analysis
  • Cancer Research and Treatments

The publication record of Brian M. Zeglis consists of papers in notable scientific venues. Frequent publication venues include:

  • Nuclear Medicine and Biology
  • Journal of Nuclear Medicine
  • Molecular Pharmaceutics
  • Bioconjugate Chemistry
  • Clinical Cancer Research

Some recent papers authored or coauthored by the scientist are:

  • "Harnessing 64Cu/ 67Cu for a theranostic approach to pretargeted radioimmunotherapy" (2020), published in Proceedings of the National Academy of Sciences
  • "Targeted Brain Tumor Radiotherapy Using an Auger Emitter" (2020), published in Clinical Cancer Research
  • "Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy" (2020), published in Frontiers in Pharmacology
  • "Click chemistry: a transformative technology in nuclear medicine" (2023), published in Nature Protocols
  • "Click Chemistry and Radiochemistry: An Update" (2023), published in Bioconjugate Chemistry

The scientist has collaborated extensively with several coauthors, indicating a networked research approach. Frequent coauthors include:

  • Outi Keinänen
  • Jason S. Lewis
  • Samantha Delaney
  • Samantha M. Sarrett
  • Cindy Rodriguez

Brian M. Zeglis's work integrates advances in radiopharmaceutical chemistry, cancer research, and innovative chemical techniques such as click chemistry. This multidisciplinary approach supports ongoing development in diagnostic imaging and therapeutic strategies within medicine.

Best Publications

  • Metallo-intercalators and metallo-insertors

    Brian M. Zeglis;Valerie C. Pierre;Jacqueline K. Barton

  • Abnormal C5-Bound N-Heterocyclic Carbenes: Extremely Strong Electron Donor Ligands and Their Iridium(I) and Iridium(III) Complexes

    Anthony R. Chianese;Anes Kovacevic;Brian M. Zeglis;J. W. Faller

  • A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels–Alder Click Chemistry

    Brian M. Zeglis;Kuntal K. Sevak;Thomas Reiner;Priya Mohindra

  • Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.

    Brian M. Zeglis;Vadim Divilov;Jason S. Lewis

  • Click Chemistry and Radiochemistry: The First 10 Years

    Jan-Philip Meyer;Pierre Adumeau;Jason S. Lewis;Brian M. Zeglis;Brian M. Zeglis

  • A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.

    Brian M. Zeglis;Jason S. Lewis

  • Pretargeted Imaging and Therapy

    Mohamed Altai;Rosemery Membreno;Brendon Cook;Vladimir Tolmachev

  • Alternative Chelator for 89Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)

    Melissa A. Deri;Shashikanth Ponnala;Shashikanth Ponnala;Brian M. Zeglis;Gabor Pohl

  • Enzyme-Mediated Methodology for the Site-Specific Radiolabeling of Antibodies Based on Catalyst-Free Click Chemistry

    Brian M. Zeglis;Charles B. Davis;Robert Aggeler;Hee Chol Kang

  • Modular Strategy for the Construction of Radiometalated Antibodies for Positron Emission Tomography Based on Inverse Electron Demand Diels–Alder Click Chemistry

    Brian M. Zeglis;Priya Mohindra;Gabriel I. Weissmann;Vadim Divilov

  • (18)F-Based Pretargeted PET Imaging Based on Bioorthogonal Diels-Alder Click Chemistry.

    Jan-Philip Meyer;Jacob L. Houghton;Paul Kozlowski;Dalya Abdel-Atti

  • The Growing Impact of Bioorthogonal Click Chemistry on the Development of Radiopharmaceuticals

    Dexing Zeng;Brian M. Zeglis;Jason S. Lewis;Carolyn J. Anderson

  • Site-Specifically Labeled Immunoconjugates for Molecular Imaging—Part 1: Cysteine Residues and Glycans

    Pierre Adumeau;Sai Kiran Sharma;Colleen Brent;Brian M. Zeglis;Brian M. Zeglis

  • Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics

    Brian M. Zeglis;Christian Brand;Dalya Abdel-Atti;Kathryn E. Carnazza

  • Fc-Mediated Anomalous Biodistribution of Therapeutic Antibodies in Immunodeficient Mouse Models

    Sai Kiran Sharma;Andrew Chow;Sebastien Monette;Delphine Vivier

  • Harnessing 64Cu/67Cu for a theranostic approach to pretargeted radioimmunotherapy.

    Outi Keinänen;Outi Keinänen;Kimberly Fung;James M Brennan;Nicholas Zia

  • Underscoring the Influence of Inorganic Chemistry on Nuclear Imaging with Radiometals

    Brian M. Zeglis;Jacob L. Houghton;Michael J. Evans;Nerissa Viola-Villegas

  • Establishment of the In Vivo Efficacy of Pretargeted Radioimmunotherapy Utilizing Inverse Electron Demand Diels-Alder Click Chemistry

    Jacob L. Houghton;Rosemery Membreno;Dalya Abdel-Atti;Kristen M. Cunanan

  • Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.

    Brian M. Zeglis;Charles B. Davis;Dalya Abdel-Atti;Sean D. Carlin

  • The Bioconjugation and Radiosynthesis of 89Zr-DFO-labeled Antibodies

    Brian M. Zeglis;Jason S. Lewis

  • H4octapa-Trastuzumab: Versatile Acyclic Chelate System for 111In and 177Lu Imaging and Therapy

    Eric W. Price;Brian M. Zeglis;Jacqueline F. Cawthray;Jacqueline F. Cawthray;Caterina F. Ramogida;Caterina F. Ramogida

  • Targeting abasic sites and single base bulges in DNA with metalloinsertors.

    Brian M. Zeglis;Jennifer A. Boland;Jacqueline K. Barton

  • An enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry

    Charles Davis;Brian Zeglis;Jason Lewis;Brian Agnew

Frequent Co-Authors

Jason S. Lewis
Jason S. Lewis Memorial Sloan Kettering Cancer Center
Jacqueline K. Barton
Jacqueline K. Barton California Institute of Technology
Chris Orvig
Chris Orvig University of British Columbia
John T. Poirier
John T. Poirier New York University Langone Medical Center
Charles M. Rudin
Charles M. Rudin Memorial Sloan Kettering Cancer Center
John L. Humm
John L. Humm Memorial Sloan Kettering Cancer Center
Ralph Weissleder
Ralph Weissleder Harvard University
Paul S. Donnelly
Paul S. Donnelly University of Melbourne
Robert H. Crabtree
Robert H. Crabtree Yale University
J. J. Dannenberg
J. J. Dannenberg City University of New York

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Chemistry in the USA opens doors to various career pathways, many of which can start with focused online education. For those interested in combining legal knowledge with scientific expertise, pursuing a criminal justice associate degree online can provide a foundation for roles in regulatory compliance or forensic chemistry. Similarly, obtaining a paralegal certificate online can complement a chemistry background by preparing individuals for legal work in patent law or environmental regulations.

Career options also extend into the pharmaceutical industry, where science meets business. Those interested in sales positions might consider the role of a pharmaceutical sales representative, a career supported by competitive earnings as outlined in the pharma sales rep salary guide. For students aiming higher, becoming a licensed pharmacist requires significant investment. Understanding how much does it cost to become a pharmacist is crucial for planning an educational trajectory and long-term career goals.

These online degrees and certifications provide flexible, accessible pathways to careers linked with chemistry, ensuring a blend of science, law, and business for graduates seeking diverse professional opportunities.

Best Scientists Citing Brian M. Zeglis

Trending Scientists

Recently Published Articles